http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110117622-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb0d9a06f4c98fe19ed3db1ae100d48e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2011-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80b3cd343395afa92ae032bbe9562c7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2849176b6c730c82fb8f62c0e454cf9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72005e3e5df05aac2d77e2023b9588ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f13d6ae011109bb43c1be4b4c8768ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eb217e27c2077a73e633daffa49644d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a7c3c46d56cf6e2efa350b0cea33178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97096c1c23dfd84ecdd99619be268f3f
publicationDate 2011-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20110117622-A
titleOfInvention Tumor Cell MiRNA Marker Composition for Anticancer Screening
abstract The present invention relates to a tumor cell miRNA marker composition for anticancer agent screening, and more particularly, to a tumor cell miRNA marker composition for anticancer agent screening having any one of SEQ ID NOs: 146 to 171. According to the present invention, when resveratrol is treated to tumor cells, miRNAs whose expression changes more than two times were found, and miRNA target genes related to apoptosis, cell cycle regulation, and cell proliferation and differentiation were found. The association between tumor cell miRNA and resveratrol identified in the present invention will serve as an important basis for the study of anti-cancer mechanism of resveratrol in tumor cells.
priorityDate 2010-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5056
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1026
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID513497
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527157
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395476
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403567
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12575
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2336
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408016
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100689061
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID461669
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID820408
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42008
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554899
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100151416
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID474890
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378493
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID476915
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12367
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID836

Total number of triples: 51.